Free Trial

Kaleido Biosciences (KLDO) Competitors

Kaleido Biosciences logo

KLDO vs. RMSG, BLBX, CSAI, CREX, MNDO, MTC, STIX, STRM, SEGG, and HKIT

Should you be buying Kaleido Biosciences stock or one of its competitors? The main competitors of Kaleido Biosciences include Real Messenger (RMSG), Blackboxstocks (BLBX), Cloudastructure (CSAI), Creative Realities (CREX), MIND C.T.I. (MNDO), MMTec (MTC), Semantix (STIX), Streamline Health Solutions (STRM), Lottery.com (SEGG), and Hitek Global (HKIT). These companies are all part of the "computer software" industry.

Kaleido Biosciences vs. Its Competitors

Kaleido Biosciences (NASDAQ:KLDO) and Real Messenger (NASDAQ:RMSG) are both small-cap computer software companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

Kaleido Biosciences' return on equity of 0.00% beat Real Messenger's return on equity.

Company Net Margins Return on Equity Return on Assets
Kaleido BiosciencesN/A N/A N/A
Real Messenger N/A -1,135.45%20.91%

In the previous week, Real Messenger had 1 more articles in the media than Kaleido Biosciences. MarketBeat recorded 1 mentions for Real Messenger and 0 mentions for Kaleido Biosciences. Real Messenger's average media sentiment score of 1.89 beat Kaleido Biosciences' score of 0.00 indicating that Real Messenger is being referred to more favorably in the news media.

Company Overall Sentiment
Kaleido Biosciences Neutral
Real Messenger Very Positive

Real Messenger has lower revenue, but higher earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A
Real MessengerN/AN/A-$3.38MN/AN/A

Kaleido Biosciences has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, Real Messenger has a beta of -0.58, meaning that its stock price is 158% less volatile than the S&P 500.

81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 37.4% of Real Messenger shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by company insiders. Comparatively, 46.6% of Real Messenger shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Real Messenger beats Kaleido Biosciences on 5 of the 9 factors compared between the two stocks.

Get Kaleido Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KLDO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KLDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KLDO vs. The Competition

MetricKaleido BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market Cap$6.39M$237.81M$5.75B$10.27B
Dividend YieldN/A3.78%5.72%4.60%
P/E Ratio0.0041.2574.9226.41
Price / SalesN/A4,870.30457.0188.61
Price / CashN/A13.1925.8129.91
Price / BookN/A126.0413.256.28
Net Income-$95.48M-$90.99M$3.29B$270.38M

Kaleido Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KLDO
Kaleido Biosciences
0.1314 of 5 stars
N/AN/AN/A$6.39M$1.10M0.0080
RMSG
Real Messenger
0.6378 of 5 stars
$2.89
+0.7%
N/AN/A$25.46MN/A0.00N/APositive News
BLBX
Blackboxstocks
0.8894 of 5 stars
$6.68
-0.4%
N/A+198.9%$25.43M$2.57M-6.2440Positive News
CSAI
Cloudastructure
2.2085 of 5 stars
$1.33
-2.9%
$6.00
+351.1%
N/A$25.22M$1.36M0.0020
CREX
Creative Realities
3.2426 of 5 stars
$2.27
-1.7%
$6.00
+164.3%
-49.6%$24.30M$50.85M-20.63100News Coverage
Analyst Upgrade
Short Interest ↓
MNDO
MIND C.T.I.
1.6167 of 5 stars
$1.20
+0.8%
N/A-37.8%$24.24M$21.45M8.57160
MTC
MMTec
1.2583 of 5 stars
$0.98
+3.1%
N/A-58.2%$23.93M$1.87M0.0060Short Interest ↓
STIX
Semantix
N/AN/AN/AN/A$23.73M$264.23M0.004
STRM
Streamline Health Solutions
N/A$5.33
flat
N/AN/A$23.23M$18.38M-2.34130
SEGG
Lottery.com
2.6598 of 5 stars
$5.82
+0.3%
N/A-30.3%$22.85M$965.08K-0.6050Analyst Forecast
HKIT
Hitek Global
1.0968 of 5 stars
$1.66
+7.1%
N/A+18.1%$22.31M$2.90M0.0075Positive News
Short Interest ↓
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:KLDO) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners